|[September 02, 2014]
Upcoming Deadline: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Regado Biosciences, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- RGDO
NEW YORK --(Business Wire)--
Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the District of New
Jersey on behalf of investors who purchased Regado Biosciences, Inc.
("Regado" or the "Company") (NasdaqCM: RGDO) securities pursuant and/or
traceable to the Company's Registration Statement and Prospectus issued
in relation to the Initial Public Offering on or about August 21, 2013,
or on the open market between August 22, 2013 and July 2, 2014.
For more information, click here: http://zk.9nl.com/regado-biosciences-rgdo.
The complaint alleges that during the Class Period defendants failed to
disclose that the danger and frequency of allergic reactions experienced
by subjects in the REG1 Phase 3 trial were significant enough to derail
the trial, and that the allergic reactions were so serious in nature
and/or frequency as to likely result in a hold on the trial.
If you suffered a loss in Regado you have until September 30, 2014 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at email@example.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/regado-biosciences-rgdo.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results
do not guarantee similar outcomes.
[ Back To Technology News's Homepage ]